Prospective evaluation of accuracy and clinical utility of the Dual Path Platform (DPP) assay for the point-of-care diagnosis of leptospirosis in hospitalized patients.

Por Scott A Nabity, José E Hagan, Guilherme Araújo, Alcinéia O Damião, Jaqueline S Cruz, Nivison Nery, Elsio A Wunder, Mitermayer G Reis, Albert I Ko, Guilherme S Ribeiro
Publicado em 2018-02-01